TR201917675A2 - A WOUND CARE PRODUCT - Google Patents
A WOUND CARE PRODUCT Download PDFInfo
- Publication number
- TR201917675A2 TR201917675A2 TR2019/17675A TR201917675A TR201917675A2 TR 201917675 A2 TR201917675 A2 TR 201917675A2 TR 2019/17675 A TR2019/17675 A TR 2019/17675A TR 201917675 A TR201917675 A TR 201917675A TR 201917675 A2 TR201917675 A2 TR 201917675A2
- Authority
- TR
- Turkey
- Prior art keywords
- care product
- wound care
- boric acid
- wound
- healing
- Prior art date
Links
- 206010052428 Wound Diseases 0.000 abstract 2
- 208000027418 Wounds and injury Diseases 0.000 abstract 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 abstract 2
- 239000004327 boric acid Substances 0.000 abstract 2
- 239000004615 ingredient Substances 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 abstract 2
- 230000029663 wound healing Effects 0.000 abstract 2
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002105 nanoparticle Substances 0.000 abstract 1
- 230000037390 scarring Effects 0.000 abstract 1
- 229910001961 silver nitrate Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
Abstract
Bu buluş, antibakteriyel bileşenleri olarak nano borik asit partikülleri ve asidik ortamda daha verimli olan antibiyotikler taşıyan, tamamlayıcı etkileri için ek bileşenler içeren bir yara bakım ürünü ile ilgilidir. Buluşun amacı, antibakteriyel bileşen olarak, teknikte sıklıkla kullanılan ancak zararlı yan etkilere sahip olan gümüş nitrat partikülleri yerine daha biyouyumlu olan borik asit nano partiküllerinin kullanıldığı, etkili salınım süresinin uzatıldığı, böylece hücre ve akyuvar proliferasyonunun indüklenmesini arttıran, yara izi bırakmadan yara iyileştirilmesini sağlayan ve yara iyileştirme sürecini hızlandıran bir yara bakım ürünü geliştirilmesidir.The present invention relates to a wound care product that contains nano boric acid particles as its antibacterial ingredients and antibiotics that are more efficient in an acidic environment, with additional ingredients for their complementary effects. The aim of the invention is to use boric acid nanoparticles, which are more biocompatible, instead of silver nitrate particles, which are frequently used in the technique but have harmful side effects, as an antibacterial component, to extend the effective release time, thus increasing the induction of cell and white blood cell proliferation, providing wound healing without scarring, and wound healing. is the development of a wound care product that accelerates the healing process.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2019/17675A TR201917675A2 (en) | 2019-11-13 | 2019-11-13 | A WOUND CARE PRODUCT |
PCT/TR2020/051083 WO2021096469A1 (en) | 2019-11-13 | 2020-11-11 | A wound care product |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2019/17675A TR201917675A2 (en) | 2019-11-13 | 2019-11-13 | A WOUND CARE PRODUCT |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201917675A2 true TR201917675A2 (en) | 2021-05-21 |
Family
ID=75912268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2019/17675A TR201917675A2 (en) | 2019-11-13 | 2019-11-13 | A WOUND CARE PRODUCT |
Country Status (2)
Country | Link |
---|---|
TR (1) | TR201917675A2 (en) |
WO (1) | WO2021096469A1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030216479A1 (en) * | 2001-11-08 | 2003-11-20 | Liren Huang | Novel compositions comprising 2,2-Bis (4-hydroxy-3-methylphenyl) heptane and uses thereof |
WO2008043175A1 (en) * | 2006-10-13 | 2008-04-17 | Kane Biotech Inc. | SOLUBLE β-N-ACETYLGLUCOSAMINIDASE BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF |
CN102223876A (en) * | 2008-09-26 | 2011-10-19 | 纳米生物公司 | Nanoemulsion therapeutic compositions and methods of using the same |
WO2011022680A2 (en) * | 2009-08-21 | 2011-02-24 | Novan, Inc. | Wound dressings, methods of using the same and methods of forming the same |
US9610282B2 (en) * | 2013-03-12 | 2017-04-04 | Nbip, Llc | Compositions and methods for preventing infection of a wound and for advancing the healing process |
-
2019
- 2019-11-13 TR TR2019/17675A patent/TR201917675A2/en unknown
-
2020
- 2020-11-11 WO PCT/TR2020/051083 patent/WO2021096469A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2021096469A1 (en) | 2021-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1121663T1 (en) | GEMCITAVINE-[PHENYL-(BENZYLOXY-L-ALANINYL)]-PHOSPHATE RP/SP MIXTURE | |
CY1124663T1 (en) | N4-HYDROXYCYTIDINE ANTIBIOTIC DERIVATIVES | |
EA201990043A1 (en) | ANTIBACTERIAL CONNECTIONS | |
GT201300232A (en) | MODULATION OF SIGNAL TRANSDUCER EXPRESSION AND TRANSCRIPTION ACTIVATOR 3 (STAT3) | |
SA517381996B1 (en) | Composition for a wound dressing | |
CY1122305T1 (en) | HYDROXAMIC ACID HYDROXAZOLE COMPOUNDS AS LPXC INHIBITORS | |
CA2919397C (en) | Aryl ethers as hif-2.alpha. inhibitors for the treatment of cancer | |
SA517381998B1 (en) | Composition for a Wound Dressing | |
PH12016501512B1 (en) | Treatment for resistant acne | |
CL2015002445A1 (en) | Amide compounds for the treatment of hiv | |
MX337577B (en) | c-KIT ANTIBODIES AND USES THEREOF. | |
EP4289910A3 (en) | Methods and compositions for wound healing | |
PH12015501576A1 (en) | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | |
MX2018001756A (en) | Substituted benzimidazoles, their preparation and their use as pharmaceuticals. | |
BR112012019286A2 (en) | bismuththiols as an antiseptic for biomedical uses, including treatment of bacterial biofilms and other uses | |
TR201909626T4 (en) | Composition containing ectoin or hydroxyectoin as promoting the healing of injured body tissue. | |
EA201691155A1 (en) | COMBINATION INHIBITORS OF HISTONDEACETYLASE AND IMMUNOMODULATING MEDICINES | |
MX2019002335A (en) | Use of collagen hydrolysate for improving endurance performance and for stimulating lipocatabolism. | |
BR112013014388A2 (en) | aqueous suspension of an encephalinase inhibitor and process for preparing an aqueous suspension | |
MX2018013240A (en) | Taurine and aloe synergistic anti-irritant compositions and methods. | |
BR112014011254A2 (en) | 2-thiopyrimidinones | |
TR201903940T4 (en) | Dressing with extended release active ingredient. | |
BR112015026388A2 (en) | wound healing methods and compositions | |
WO2017136731A8 (en) | Rapaglutins, novel inhibitors of glut and use thereof | |
MX2018006953A (en) | Monomaleimide-functionalized platinum compounds for cancer therapy. |